Clinical Trials Logo

Vaginal Prolapse clinical trials

View clinical trials related to Vaginal Prolapse.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06234449 Not yet recruiting - Clinical trials for Pelvic Organ Prolapse

The Impact of Long-term Pessary Use on Pelvic Organ Prolapse oìduring Covid-19 Pandemic in Patients Attending Surgery

Start date: July 2024
Phase:
Study type: Observational [Patient Registry]

Patients aged 45 to 80 years with a clinical diagnosis of stage III and IV genital prolapse involving the anterior and/or middle compartments and candidates for surgery will be considered. These will be evaluated to observe whether there is improvement in clinical prolapse with the use of the vaginal pessary during the waiting period for surgery

NCT ID: NCT04078802 Not yet recruiting - Vaginal Prolapse Clinical Trials

0050-19-RMB CTIL - VNOTES Compared to VH for Vaginal Apex Prolapse

Start date: October 2019
Phase: N/A
Study type: Interventional

VNOTES (Transvaginal natural orifice transluminal endoscopic surgery) is a relatively new surgery for Hysterectomy and Uterosacral ligament suspension to treat Vaginal prolapse. The investigators wish to run a randomized control trial comparing it to classic Vaginal hysterectomy for the same indication.

NCT ID: NCT03333811 Not yet recruiting - Vaginal Prolapse Clinical Trials

Sexual Function After Vaginal Repair With Perineorrhaphy

Start date: February 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if perineorrhaphy performed with surgical vaginal prolapse repair improves sexual function.

NCT ID: NCT00627549 Not yet recruiting - Vaginal Prolapse Clinical Trials

Avaulta Versus Anterior Repair

Start date: n/a
Phase: N/A
Study type: Interventional

Summary: Vaginal prolapse is a well-known disease and is observed in approximately 11% of all postmenopausal women and tending to increase with age. Consequently, many surgical procedures have been developed in order to ensure sufficient support for the bladder, rectum or vaginal vault depending on the site of the defect. However, many procedures are associated with a high recurrence rate up to 40 % even within one to two years after the surgical procedure. Due to the high recurrence rate new methods include the use of mesh, either biologically or synthetic. The latter is a permanent implant and therefore theoretically may result in a long-lasting anatomically correct position of the prolapse. Although the recurrence rate may be lower using a mesh such surgical procedures may be associated with adverse events such as erosions of the vaginal mucosa. Others have observed shrinkage of the vaginal mucosa. However, in these studies large prolene mesh have been used. In contrast the recurrence rate is lowered up to 25%. The above-mentioned advantage of synthetic mesh is however, mostly based on few non-randomised studies. We therefore find it of importance to evaluate whether a surgical procedure using a mesh implant is superior to conventional surgical techniques. The present study is a clinical controlled study where patients with anterior vaginal prolapse are randomised to either a mesh technique or a standard anterior procedure. The present study includes only two more visits at the outpatient clinic after the surgical procedure. Furthermore the patients have to fulfil questionnaires regarding urinary and faecal leakage and sexual habits. Any participation in the study is totally voluntary and the patient may at any time withdraw herself. In any case the patient will receive our standard treatment. The study is performed in all the Scandinavian countries.